Quo Lab takes off in Italy
In a drive to improve management of diabetes in the Lazio region of Italy, Quo-Lab® glycated hemoglobin (HbA1c) analyzers are being installed in all hospitals within the territory. This new initiative is part of a bold campaign to allow clinicians and patients better access to HbA1c testing to aid in the management and treatment of diabetes.
The video, originally broadcast on Italian national television, shows the Quo-Lab being used in daily routine as well as specialist diabetes clinics. The Quo-Lab analyzer is a dedicated HbA1c system, designed to deliver quick and cost effective results at the point-of-care, allowing physicians greater engagement with patients.